Logo

Don Lindberg

Nov 10, 2014

Don Lindberg, who has been the director of the National Library of Medicine for more than 30 years, will retire at the end of March 2015, NIH Director Francis Collins said this week. Lindberg created the National Center for Biomedical Information, and he introduced numerous projects including free Internet access to MEDLINE via PubMed, MedlinePlus for the general public, the Visible Human Project, ClinicalTrials.gov, the Unified Medical Language System, and more, Collins said.

Lindberg also was founding director of the National Coordination Office for High Performance Computing and Communications in the President's Office of Science and Technology Policy and was named by the HHS Secretary to be the US National Coordinator for the G-7 Global Healthcare Applications Project. In addition, he was the first president of the American Medical Informatics Association.

"Don has created programs that changed fundamentally the way biomedical information is collected, shared, and analyzed," Collins said in a statement.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.